Cytomegalovirus infection during pregnancy

Area of Science:

• Obstetrics and Gynecology
• Infectious Diseases
• Pediatrics

Background:

• Cytomegalovirus (CMV) infection during pregnancy is a significant global health concern, often unrecognized.
• It is the leading cause of congenital infections, leading to sensorineural hearing loss and neurodevelopmental delays in infants.
• Lack of awareness among healthcare professionals and the public, coupled with asymptomatic presentations and diagnostic challenges, contributes to its underestimation.

Purpose of the Study:

• To provide an updated overview of the epidemiology, transmission, and clinical aspects of CMV infection in pregnant women and newborns.
• To review current diagnostic methods, including screening and prognostic markers.
• To highlight recent advancements in management, including treatment modalities, vaccination research, and hyperimmunoglobulin therapies.

Main Methods:

• Literature review focusing on recent research and clinical guidelines.
• Synthesis of information on CMV pathophysiology, clinical manifestations, and diagnostic approaches.
• Analysis of current and emerging treatment strategies and preventative measures.

Main Results:

• CMV infection presents significant risks for congenital transmission and adverse infant outcomes.
• Diagnostic challenges persist due to asymptomatic maternal and neonatal infections.
• New therapeutic and preventative strategies, including vaccines and hyperimmunoglobulins, are under active investigation.

Conclusions:

• Increased global awareness and recognition of CMV infection in pregnancy are crucial.
• Improved diagnostic tools and screening protocols are needed.
• Continued research into vaccines and effective treatments is essential for mitigating the impact of congenital CMV.